(Q37953796)

25 August 2017

title

New-generation vaccines against cholera (English)

1 reference

25 August 2017

0 references

5

Jan Holmgren

1 reference

25 August 2017

1

John Clemens

1 reference

25 August 2017

3

Dipika Sur

1 reference

25 August 2017

2

Sunheang Shin

1 reference

25 August 2017

G Balakrish Nair

4

1 reference

25 August 2017

language of work or name

English

0 references

publication date

8 November 2011

1 reference

Nature Reviews Gastroenterology & Hepatology

25 August 2017

published in

1 reference

25 August 2017

volume

8

1 reference

25 August 2017

issue

12

1 reference

25 August 2017

page(s)

701-710

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

25 August 2017

1 reference

21 January 2018

Cholera's western front

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

A lion in our village--the unconscionable tragedy of cholera in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

CTXphi and Vibrio cholerae: exploring a newly recognized type of phage-host cell relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Cholera in Africa: A Message for the West

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Cholera in Mozambique, variant of Vibrio cholerae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Classical ctxB in Vibrio cholerae O1, Kolkata, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Vibrio cholerae O1 hybrid El Tor strains, Asia and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

The origin of the Haitian cholera outbreak strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Cholera--a possible endemic focus in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Algal blooms in the spread and persistence of cholera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Host-induced epidemic spread of the cholera bacterium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Hyperinfectivity of human-passaged Vibrio cholerae can be modeled by growth in the infant mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Cannabis, hypochlorhydria, and cholera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Acid tolerance of gastrointestinal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Protection against cholera in breast-fed children by antibodies in breast milk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

ABO blood group distributions in diarrhoea cases including cholera in Calcutta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Association between O blood group and occurrence and severity of diarrhoea due to Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Contribution of hemagglutinin/protease and motility to the pathogenesis of El Tor biotype cholera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Going against the grain: chemotaxis and infection in Vibrio cholerae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Mechanisms of Disease and Immunity in Cholera: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Natural cholera infection-derived immunity in an endemic setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Waldemar Haffkine's cholera vaccines and the Ferran-Haffkine priority dispute.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Biotype as determinant of natural immunising effect of cholera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Oral vaccines against cholera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

An oral B subunit: whole cell vaccine against cholera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Field trial of oral cholera vaccines in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Effectiveness of mass oral cholera vaccination in Beira, Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Cholera vaccines for the developing world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Can oral cholera vaccination play a role in controlling a cholera outbreak?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Controlling endemic cholera with oral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Vaccination strategies for epidemic cholera in Haiti with implications for the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

The case for reactive mass oral cholera vaccinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Resistance of the cholera vaccine candidate IEM108 against CTXPhi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Construction and Evaluation of a Safe, Live, Oral Vibrio cholerae Vaccine Candidate, IEM108

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

A national cholera vaccine stockpile--a new humanitarian and diplomatic resource

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Recombinant attenuated Vibrio cholerae strains used as live oral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Onset and Duration of Protective Immunity in Challenged Volunteers after Vaccination with Live Oral Cholera Vaccine CVD l03-HgR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

21 January 2018

12 December 2020

Endemic cholera in rural Bangladesh, 1966-1980.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Cholera in Portugal, 1974.I. Modes of transmission

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Epidemic cholera in the Amazon: the challenge of preventing death.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Outbreak of Vibrio cholerae non-O1 in India and Bangladesh

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

El Tor cholera with severe disease: a new threat to Asia and beyond

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Depletion of hepatic glycogen in the hypoglycaemia of fatal childhood diarrhoeal illnesses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Cholera, copepods, and chitinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Breast feeding and the risk of severe cholera in rural Bangladeshi children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Predisposition for cholera of individuals with O blood group. Possible evolutionary significance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Subunit structure of cholera toxin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Fixation and inactivation of cholera toxin by GM1 ganglioside

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Lack of cross-protection against diarrhea due to Vibrio cholerae O1 after oral immunization of rabbits with V. cholerae O139 Bengal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Epidemic and endemic cholera trends over a 33-year period in Bangladesh

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Effect of neutralization of gastric acid on immune responses to an oral B subunit, killed whole-cell cholera vaccine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Misleading negative findings in a field trial of killed, oral cholera vaccine in Peru

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Increase in plasma viral load after oral cholera immunization of HIV-infected subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Genetic diversity of El Tor strains of Vibrio cholerae O1 with hybrid traits isolated from Bangladesh and Mozambique

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Evaluation of Peru-15, a new live oral vaccine for cholera, in volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Construction and characterisation of O139 cholera vaccine candidates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.174

Cholera due to the E1 Tor biotype equals the classical biotype in severity and attack rates

31 March 2020

1 reference

12 December 2020

Development of the cholera epidemic in western Africa

1 reference

12 December 2020

Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.

1 reference

12 December 2020

Colonization of the gut of the blue crab (Callinectes sapidus) by Vibrio cholerae

1 reference

12 December 2020

Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique

1 reference

12 December 2020

Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observation

1 reference

12 December 2020

Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam

1 reference

12 December 2020

Nationwide prevalence of the new epidemic strain of Vibrio cholerae O139 Bengal in India

1 reference

12 December 2020

Vibrio cholerae CVD103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effects.

1 reference

12 December 2020

Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination

1 reference

12 December 2020

The spectrum of cholera in rural Bangladesh. II. Comparison of El Tor Ogawa and classical Inaba infection

1 reference

12 December 2020

Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh

1 reference

12 December 2020

Effectiveness of mass vaccination with WC/rBS cholera vaccine during an epidemic in Adjumani district, Uganda

1 reference

12 December 2020

Impact of B subunit killed whole-cell and killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera

1 reference

12 December 2020

Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine.

1 reference

12 December 2020

Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection

1 reference

12 December 2020

Cholera vaccines: WHO position paper

1 reference

12 December 2020

1 reference

12 December 2020

Cholera: diagnosis and treatment

1 reference

12 December 2020

Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial

1 reference

12 December 2020

Cholera and the immune response

1 reference

12 December 2020

Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up

1 reference

12 December 2020

Ecological relationships between Vibrio cholerae and planktonic crustacean copepods.

1 reference

12 December 2020

Influence of water temperature, salinity, and pH on survival and growth of toxigenic Vibrio cholerae serovar 01 associated with live copepods in laboratory microcosms.

1 reference

12 December 2020

ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy

1 reference

12 December 2020

Attachment of toxigenic Vibrio cholerae 01 to various freshwater plants and survival with a filamentous green alga, Rhizoclonium fontanum

1 reference

12 December 2020

Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers

1 reference

12 December 2020

Immune response following oral administration of cholera toxin B subunit to HIV-1-infected UK and Kenyan subjects.

1 reference

12 December 2020

Gastric acidity in cholera and noncholera diarrhoea

1 reference

12 December 2020

Vibrio cholerae O139 Bengal: the eighth pandemic strain of cholera

1 reference

12 December 2020

The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients

1 reference

12 December 2020

A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali

1 reference

12 December 2020

Identification and characterization of cholera exotoxin in culture filtrates of V. cholerae

1 reference

12 December 2020

Cholera vaccine field trials in east Pakistan. 1. Reaction and antigenicity studies

1 reference

12 December 2020

1 reference

12 December 2020

10.1038/NRGASTRO.2011.174

Identifiers

DOI

1 reference

25 August 2017

1 reference